L.A.M. Frenken

1.0k total citations
21 papers, 406 citations indexed

About

L.A.M. Frenken is a scholar working on Hematology, Nephrology and Molecular Biology. According to data from OpenAlex, L.A.M. Frenken has authored 21 papers receiving a total of 406 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 7 papers in Nephrology and 5 papers in Molecular Biology. Recurrent topics in L.A.M. Frenken's work include Erythropoietin and Anemia Treatment (10 papers), Dialysis and Renal Disease Management (5 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). L.A.M. Frenken is often cited by papers focused on Erythropoietin and Anemia Treatment (10 papers), Dialysis and Renal Disease Management (5 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). L.A.M. Frenken collaborates with scholars based in Netherlands, Belgium and Germany. L.A.M. Frenken's co-authors include R. A. P. Koene, Theo Verrips, Bernard de Geus, W Stok, W.J.M. Tax, Karel M.L. Leunissen, Frank M. van der Sande, R A Koene, Henk J.J. van Lier and P. Michielsen and has published in prestigious journals such as Kidney International, American Journal of Kidney Diseases and Transplantation.

In The Last Decade

L.A.M. Frenken

19 papers receiving 377 citations

Peers

Countries citing papers authored by L.A.M. Frenken

Since Specialization

Citations

This map shows the geographic impact of L.A.M. Frenken's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L.A.M. Frenken with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L.A.M. Frenken more than expected).

Fields of papers citing papers by L.A.M. Frenken

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L.A.M. Frenken. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L.A.M. Frenken. The network helps show where L.A.M. Frenken may publish in the future.

Co-authorship network of co-authors of L.A.M. Frenken

This figure shows the co-authorship network connecting the top 25 collaborators of L.A.M. Frenken. A scholar is included among the top collaborators of L.A.M. Frenken based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L.A.M. Frenken. L.A.M. Frenken is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The spectrum of thrombotic microangiopathy related to monoclonal gammopathy 2024 ·Clinical Kidney Journal ·(unknown), Myrurgia A. Abdul‐Hamid, L.A.M. Frenken, Pieter van Paassen, Sjoerd A.M.E.G. Timmermans, (unknown)	3
2	Primary Podocytopathies After COVID-19 Vaccination 2021 ·Kidney International Reports ·Sjoerd A.M.E.G. Timmermans, Matthias H. Busch, Myrurgia A. Abdul‐Hamid, L.A.M. Frenken, Albert‐Jan L.H.J. Aarnoudse, Pieter van Paassen	9
3	Renal Function of Pre-Dialysis Patients during Treatment with Recombinant Human Erythropoietin 2015 ·Contributions to nephrology ·R. A. P. Koene, L.A.M. Frenken	0
4	Treatment of Predialysis Patients with Recombinant Human Erythropoietin 2015 ·Contributions to nephrology ·R. A. P. Koene, L.A.M. Frenken, Jack F.M. Wetzels, Henk E. Sluiter, G Schrijver, R. Verberckmoes, P. Michielsen	0
5	Does Treatment of Predialysis Patients with Recombinant Human Erythropoietin Compromise Renal Function? 2015 ·Contributions to nephrology ·R. A. P. Koene, L.A.M. Frenken	3
6	Insight Into Advance Care Planning for Patients on Dialysis 2012 ·Journal of Pain and Symptom Management ·Daisy J.A. Janssen, Martijn A. Spruit, Jos M. G. A. Schols, Frank M. van der Sande, L.A.M. Frenken, Emiel F.�M. Wouters	38
7	Simultaneous Blood Temperature Control and Blood Volume Control Reduces Intradialytic Symptoms 2011 ·The International Journal of Artificial Organs ·(unknown), (unknown), Milan Radović, (unknown), W Ries, L.A.M. Frenken, Ralf Wojke	6
8	An evaluation of blood volume changes during ultrafiltration pulses and natriuretic peptides in the assessment of dry weight in hemodialysis patients 2007 ·Hemodialysis International ·(unknown), L.A.M. Frenken, (unknown), Ruben Baumgarten, Frank M. van der Sande, (unknown), Jeroen P. Kooman, Karel M.L. Leunissen	31
9	Induction of immune responses and molecular cloning of the heavy chain antibody repertoire of Lama glama 2000 ·Journal of Immunological Methods ·(unknown), Bernard de Geus, W Stok, (unknown), (unknown), Theo Verrips, L.A.M. Frenken	110
10	ROLE OF POLYMORPHIC Fc RECEPTOR Fc??RIIa IN CYTOKINE RELEASE AND ADVERSE EFFECTS OF MURINE IgG1 ANTI-CD3/T CELL RECEPTOR ANTIBODY (WT31)1 1997 ·Transplantation ·W.J.M. Tax, Wim P.M. Tamboer, Cor Jacobs, L.A.M. Frenken, R. A. P. Koene	26
11	Keynote Lecture: Starting r-HuEPO in chronic renal failure: when, why, and how? 1995 ·Nephrology Dialysis Transplantation ·R. A. P. Koene, L.A.M. Frenken	21
12	Polymorphism of Fc receptor (Fc gamma RII) is reflected in cytokine release and adverse effects of mIgG1 anti-CD3/TCR antibody during rejection treatment after renal transplantation. 1995 ·PubMed ·W.J.M. Tax, L.A.M. Frenken, (unknown), Wim P.M. Tamboer, R A Koene	4
13	Identification of the Component Part in an Epoetin Alfa Preparation That Causes Pain After Subcutaneous Injection 1993 ·American Journal of Kidney Diseases ·L.A.M. Frenken, Henk J.J. van Lier, J. G. M. Jordans, Karel M.L. Leunissen, R. van Leusen, (unknown), R. A. P. Koene	40
14	Erythropoietin: mechanisms of action and indications for treatment. 1993 ·PubMed ·Gerard Vreugdenhil, L.A.M. Frenken, R A Koene	2
15	Evidence for renal vasodilation in pre-dialysis patients during correction of anemia by erythropoietin 1992 ·Kidney International ·L.A.M. Frenken, Jack F.M. Wetzels, Henk E. Sluiter, R. A. P. Koene	10
16	Intraperitoneal Administration of Recombinant Human Erythropoietin 1992 ·Peritoneal Dialysis International ·L.A.M. Frenken, Dirk G. Struijk, (unknown), (unknown), Raymond T. Krediet, R. A. P. Koene	9
17	Assessment of pain after subcutaneous injection of erythropoietin in patients receiving haemodialysis. 1991 ·BMJ ·L.A.M. Frenken, H J van Lier, P. G. G. Gerlag, (unknown), R A Koene	28
18	THE ROLE OF ANTIBODY ISOTYPE IN IFN-γ AND IL-2 PRODUCTION DURING ANTI-CD3-INDUCED T CELL PROLIFERATION 1991 ·Transplantation ·L.A.M. Frenken, R. A. P. Koene, W.J.M. Tax	18
19	Prophylactic use of anti-CD3 monoclonal antibody WT32 in kidney transplantation. 1991 ·PubMed ·L.A.M. Frenken, A. J. Hoitsma, W.J.M. Tax, R A Koene	6
20	Efficacy and Tolerance of Treatment with Recombinant-Human Erythropoietin in Chronic Renal Failure (Pre-Dialysis) Patients 1989 ·Nephrology Dialysis Transplantation ·L.A.M. Frenken, R. Verberckmoes, P. Michielsen, R. A. P. Koene	33

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact